Intensive invidualized induction therapy with behenoyl, cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults

R. Ohno, S. Yokomaku, M. Okumura, T. Nagai, K. Kitaori, T. Ito, T. Takeo, I. Sugiura, K. Yano, Y. Ito, T. Kataoka, M. Hamaguchi, K. Adachi, M. Tanimoto, M. Ogura, Y. Morishita, Y. Morishima, K. Kawashima, S. Minami

Research output: Contribution to journalArticle

4 Citations (Scopus)

Fingerprint Dive into the research topics of 'Intensive invidualized induction therapy with behenoyl, cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine, mitoxantron, etoposide and vinca alkaloids in acute myeloid leukemia in adults'. Together they form a unique fingerprint.

Medicine & Life Sciences